WOCKHARDT
|
The Current P/S Ratio of WOCKHARDT is 5.94.
Share Price | ₹1,120.8 | Oct 28,2024 |
Market Cap | ₹17,193.1 Cr | |
Sales-TTM | ₹2,893.0 Cr | TTM-Consolidated Results |
Price/Sales | 5.94x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of WOCKHARDT
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹17,193.1 Cr] as on Oct 28,2024
(/) Sales [ ₹2,893.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.94x ]
Thus, for WOCKHARDT , the investors are currently willing to pay '5.94 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WOCKHARDT !
The chart below summarizes the trend in P/S Ratio of WOCKHARDT over the last five years.
Historical PS (Price/Sales) ratio chart of WOCKHARDT
PS Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.52x.
- WOCKHARDT 's operated at median p/e ratio of 1.18x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2024 at 3.21x.
- WOCKHARDT 's p/e ratio hit its five-year low in Mar2020 of 0.67x.
How does WOCKHARDT 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
WOCKHARDT | 2,893.0 | 5.94 | 17,193.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 9.07 | 456,509.0 |
CIPLA LTD | 26,139.1 | 4.65 | 121,422.0 |
DR REDDYS LABORATORIES LTD | 28,949.3 | 3.78 | 109,505.0 |
ZYDUS LIFESCIENCES LTD | 20,615.3 | 4.91 | 101,293.0 |
DIVIS LABORATORIES LTD | 8,185.0 | 18.84 | 154,240.0 |
MANKIND PHARMA LTD | 10,649.6 | 9.14 | 97,300.4 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.99 | 112,171.0 |
LUPIN LTD | 20,797.1 | 4.83 | 100,550.0 |
AUROBINDO PHARMA LTD | 29,718.4 | 2.80 | 83,278.2 |
ABBOTT INDIA LTD | 5,927.5 | 10.18 | 60,360.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WOCKHARDT 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.80x |
Max industry PS | 18.84x |
Median industry PS | 5.94x |
Average industry PS | 7.65x |
You may also like the below Video Courses